Skip to main content
Log in

Comparative Pharmacokinetics and Relative Bioavailability of a New Anxiolytic GML-1 in Tablet Form

  • Published:
Moscow University Chemistry Bulletin Aims and scope

Abstract

An open, single, crossover, pharmacokinetic study of GML-1 (dose 50 mg/kg) in rabbits after its oral administration in tablets and alone as a substance is carried out. The following pharmacokinetic parameters are calculated: the maximum concentration of GML-1 in blood plasma (Cmax) of rabbits, the time required to reach Cmax, the area under the concentration-time curve, the half-time of GML-1, and the relative bioavailability. The GML-1 concentration is detected with the use of the HPLC-MS (ion trap) by the daughter ions. The relative bioavailability of GML-1 in tablets is 101.72 ± 19.96% in comparison to the substance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.

Similar content being viewed by others

REFERENCES

  1. Yarkova, M.A., Mokrov, G.V., Gudasheva, T.A., and Seredenin, S.B., Pharm. Chem. J., 2016, vol. 50, no. 8, p. 501.

    Article  CAS  Google Scholar 

  2. Kang, H.Ch., Huh, K.M., and Bae, Y.H., J. Controlled Release, 2012, vol. 164, no. 3, p. 256.

    Article  CAS  Google Scholar 

  3. Bardakov, A.I., Litvin, A.A., and Slivkin, A.I., Biofarmatsevticheskie podkhody v razrabotke i otsenke gotovykh lekarstvennykh form (Biopharmaceutical Approaches in the Development and Evaluation of Finished Dosage Forms), Krasnyuk, I.I., Ed., Voronezh: Voronezh. Gos. Univ., 2010.

    Google Scholar 

  4. Firsov, A.A., Zherdev, V.P., Portnoi, Yu.A., et al., Rukovodstvo po provedeniyu doklinicheskikh issledovanii lekarstvennykh sredstv (Guidelines for Conducting Preclinical Studies of Pharmaceutical Preparations), Mironov, A.N., Ed., Moscow: Grif, 2013, part 1.

  5. Novitskiy, A.A., Bochkov, P.O., Litvin, A.A., Zherdev, V.P., and Blynskaya, E.V., Moscow Univ. Chem. Bull. (Engl. Transl.), 2017, vol. 72, no. 6, p. 322.

    Article  Google Scholar 

  6. Validatsiya analiticheskikh metodik dlya proizvoditelei lekarstv. Tipovoe rukovodstvo predpriyatiya po proizvodstvu lekarstvennykh sredstv (Validation of Analytical Methods for Drug Manufacturers: Model Guide of the Company for the Production of Medicines), Beregovykh, V.V., Ed., Moscow: Littera, 2008.

    Google Scholar 

  7. Sergienko, V.I. and Bondareva, I.B., Matematicheskaya statistika v klinicheskikh issledovaniyakh (Mathematical Statistics in Clinical Studies), Moscow: GEOTAR-Media, 2001.

Download references

Funding

This study was supported by the Ministry of Education and Science (state contract no. 14. N08.12.0087).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. A. Litvin.

Ethics declarations

Conflict of interest. The authors declare that they have no conflict of interest.

Statement on the welfare of animals. All applicable international, national and/or institutional principles for the care and use of animals were followed.

Additional information

Translated by M. Novikova

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Novitskiy, A.A., Litvin, A.A., Shevchenko, R.V. et al. Comparative Pharmacokinetics and Relative Bioavailability of a New Anxiolytic GML-1 in Tablet Form. Moscow Univ. Chem. Bull. 74, 204–207 (2019). https://doi.org/10.3103/S0027131419040060

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.3103/S0027131419040060

Keywords:

Navigation